BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 911166)

  • 1. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
    Price NM
    Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
    Vonderheid EC
    Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical mechlorethamine therapy for mycosis fungoides.
    Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
    Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of mycosis fungoides with ointment-based mechlorethamine.
    Price NM; Deneau DG; Hoppe RT
    Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy.
    Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM
    Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanogenesis from topical mechlorethamine and analogues in skin of hairless mice and in vitiligo.
    Van Scott EJ; Yu RJ
    J Invest Dermatol; 1975 Nov; 65(5):476-8. PubMed ID: 1194712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mycosis fungoides].
    Volden G; Eeg Larsen T
    Tidsskr Nor Laegeforen; 1977 Nov; 97(32):1671-5. PubMed ID: 594965
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical chemotherapy in mycosis fungoides.
    Grupper C; Durepaire R
    Bull Cancer; 1977; 64(2):323-34. PubMed ID: 912134
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical chemotherapy of mycosis fungoides.
    Grekin DA; Zackheim HS; Epstein EH
    Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Hyperpigmentation after cancer chemotherapy.
    O'Doherty CS
    Lancet; 1975 Aug; 2(7930):365-6. PubMed ID: 51171
    [No Abstract]   [Full Text] [Related]  

  • 13. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary and update: topical chemotherapy with mechlorethamine for mycosis fungoides.
    Vonderheid EC; Van Scott EJ
    Cleve Clin Q; 1983; 50(2):97-100. PubMed ID: 6640944
    [No Abstract]   [Full Text] [Related]  

  • 16. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
    Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
    J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical cutaneous changes after topical treatment with nitrogen mustard in patients with mycosis fungoides.
    Reddy VB; Ramsay D; Garcia JA; Kamino H
    Am J Dermatopathol; 1996 Feb; 18(1):19-23. PubMed ID: 8721586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
    Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
    JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
    Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
    Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.